Advertisement
The Journal of Heart and Lung Transplantation
International Society for Heart and Lung Transplantation.

Pre-Operative Sarcopenia is Predictive of Recurrent Gastrointestinal Bleeding on Left Ventricular Assist Device Support: A Multicenter Analysis

Sarcopenia is Predictive of GI Bleeding After LVAD
Published:January 08, 2022DOI:https://doi.org/10.1016/j.healun.2022.01.004

      Abstract

      Introduction

      Whether pre left ventricular assist device (LVAD) sarcopenia is associated with higher incidence of gastrointestinal bleeding (GIB) on LVAD support remains unknown.

      Methods

      To study the association between preoperative sarcopenia and post LVAD GIB events, we performed a retrospective, multi-centered study including patients with chest CTs performed ≤ 3 months prior to LVAD implantation at the University of Minnesota (n=143) and Houston Methodist Hospital (n=133). To quantify sarcopenia, unilateral pectoralis muscle mass indexed to body surface area (PMI) and attenuation (approximated by mean Hounsfield units; PHUm) were measured on pre-operative chest CT scans. Negative binomial regression analyses were performed to determine the association between pectoralis muscle measures and number of GIB events to 2 years of LVAD support.

      Results

      The study cohort included 276 LVAD recipients with 43 % designated as bridge to transplant at the time of LVAD implantation. High pectoralis muscle mass and tissue attenuation were both protective against GIB events. Each 5 unit increase in PHUm was associated with an adjusted 19 % reduction in the incidence rate of GIB (95 % CI 7-29 %, p = 0.002). Each unit increase in PMI was associated with an adjusted 17 % reduction in the incidence of GIB (95 % CI 1- 29 %, p = 0.04). The models were adjusted for age, sex, INTERMACS profile, bridge to transplant status, creatinine, albumin and implanting center.

      Conclusion

      Preoperative sarcopenia, as quantified by pectoralis muscle size and attenuation, was associated with the development of recurrent GI bleeding after LVAD implantation. These CT quantitative measures appear to predict not only early mortality but morbidity on LVAD as well.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Heart and Lung Transplantation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • John R
        • Kamdar F
        • Eckman P
        • et al.
        Lessons learned from experience with over 100 consecutive HeartMate II left ventricular assist devices.
        Ann Thorac Surg. Nov 2011; 92 (discussion 1599-600): 1593-1599https://doi.org/10.1016/j.athoracsur.2011.06.081
        • Kormos RL
        • Cowger J
        • Pagani FD
        • et al.
        The Society of Thoracic Surgeons Intermacs database annual report: Evolving indications, outcomes, and scientific partnerships.
        J Heart Lung Transplant. Feb 2019; 38: 114-126https://doi.org/10.1016/j.healun.2018.11.013
        • Mehra MR
        • Salerno C
        • Cleveland JC
        • et al.
        Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study.
        Circulation. Oct 30 2018; 138: 1923-1934https://doi.org/10.1161/circulationaha.118.035722
        • Joy PS
        • Kumar G
        • Guddati AK
        • Bhama JK
        • Cadaret LM.
        Risk Factors and Outcomes of Gastrointestinal Bleeding in Left Ventricular Assist Device Recipients.
        Am J Cardiol. Jan 15 2016; 117: 240-244https://doi.org/10.1016/j.amjcard.2015.10.041
        • Starling RC
        • Estep JD
        • Horstmanshof DA
        • et al.
        Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: The ROADMAP Study 2-Year Results.
        JACC Heart Fail. Jul 2017; 5: 518-527https://doi.org/10.1016/j.jchf.2017.02.016
        • Estep JD
        • Starling RC
        • Horstmanshof DA
        • et al.
        Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: Results From the ROADMAP Study.
        J Am Coll Cardiol. Oct 20 2015; 66: 1747-1761https://doi.org/10.1016/j.jacc.2015.07.075
        • Critsinelis AC
        • Kurihara C
        • Kawabori M
        • et al.
        Predictive value of preoperative serum albumin levels on outcomes in patients undergoing LVAD implantation.
        Journal of Cardiac Surgery. 2018; 33: 469-478https://doi.org/10.1111/jocs.13745
        • Cogswell R
        • Trachtenberg B
        • Murray T
        • et al.
        A Novel Model Incorporating Pectoralis Muscle Measures to Predict Mortality After Ventricular Assist Device Implantation.
        Journal of Cardiac Failure. 2020; 26 (/04/01/2020): 308-315https://doi.org/10.1016/j.cardfail.2019.11.021
        • Teigen LM
        • John R
        • Kuchnia AJ
        • et al.
        Preoperative Pectoralis Muscle Quantity and Attenuation by Computed Tomography Are Novel and Powerful Predictors of Mortality After Left Ventricular Assist Device Implantation.
        Circ Heart Fail. Sep 2017; 10https://doi.org/10.1161/CIRCHEARTFAILURE.117.004069
        • Kinsey CM
        • San Jose Estepar R
        • van der Velden J
        • Cole BF
        • Christiani DC
        • Washko GR
        Lower Pectoralis Muscle Area Is Associated with a Worse Overall Survival in Non-Small Cell Lung Cancer.
        Cancer Epidemiol Biomarkers Prev. Jan 2017; 26: 38-43https://doi.org/10.1158/1055-9965.EPI-15-1067
        • Johannesdottir F
        • Allaire B
        • Anderson DE
        • Samelson EJ
        • Kiel DP
        • Bouxsein ML.
        Population-based study of age- and sex-related differences in muscle density and size in thoracic and lumbar spine: the Framingham study.
        Osteoporosis International. 2018; 29 (2018/07/01): 1569-1580https://doi.org/10.1007/s00198-018-4490-0
        • Kapuria D
        • Khumri T
        • Shamim S
        • et al.
        Characterization and timing of gastrointestinal bleeding in continuous flow left ventricular assist device recipients.
        Heliyon. 2020; 6 (2020/09/01/): e04695https://doi.org/10.1016/j.heliyon.2020.e04695
        • Tsuchida K
        • Tanaka K
        • Nakano K
        • et al.
        P10 A possible link between sarcopenia and major bleeding risk among patients with atrial fibrillation treated with oral anticoagulation undergoing coronary stenting.
        European Heart Journal. 2020; 41https://doi.org/10.1093/ehjci/ehz872.016
        • Valentova M
        • von Haehling S
        • Bauditz J
        • et al.
        Intestinal congestion and right ventricular dysfunction: a link with appetite loss, inflammation, and cachexia in chronic heart failure.
        European Heart Journal. 2016; 37: 1684-1691https://doi.org/10.1093/eurheartj/ehw008
        • Liebo M
        • Newman J
        • Yu M
        • et al.
        Preoperative Right Heart Dysfunction and Gastrointestinal Bleeding in Patients with Left Ventricular Assist Devices.
        Asaio j. Mar 1 2021; 67: 324-331https://doi.org/10.1097/mat.0000000000001224
      1. Tomizawa Y, Tanaka A, Kitahara H, et al. Preoperative Right-Sided Cardiac Congestion Is Associated with Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices. Dig Dis Sci. Jun 2018;63(6):1518-1524. doi:10.1007/s10620-018-4916-8

        • Yin MY
        • Ruckel S
        • Kfoury AG
        • et al.
        Novel Model to Predict Gastrointestinal Bleeding During Left Ventricular Assist Device Support.
        Circ Heart Fail. Nov 2018; 11e005267https://doi.org/10.1161/circheartfailure.118.005267
        • Hersberger L
        • Dietz A
        • Bürgler H
        • et al.
        Individualized Nutritional Support for Hospitalized Patients With Chronic Heart Failure.
        Journal of the American College of Cardiology. 2021; 77 (2021/05/11/): 2307-2319https://doi.org/10.1016/j.jacc.2021.03.232